US Patent 7326679 Anticancer peptide compositions
Patent 7326679 was granted and assigned to TranXenoGen, Inc. on February, 2008 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7326679 Anticancer peptide compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.